GSK plc (GSK)

Switzerland
Currency in CHF
19.98
0.00(0.00%)
Closed
GSK Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
19.9819.98
52 wk Range
0.0019.98
Key Statistics
Edit
Prev. Close
20.18
Open
19.98
Day's Range
19.98-19.98
52 wk Range
0-0
Volume
-
Average Volume (3m)
7.51K
1-Year Change
0%
Book Value / Share
3.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GSK Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

GSK plc Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and Relation Therapeutics, using their Lab in the Loop platform to discover novel targets for osteoarthritis, systemic sclerosis and other fibrotic mechanisms, supporting data-tech driven approach in respiratory, immunology and inflammation; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson’s disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, the United Kingdom.

Industry
-
Sector
-
Employees
68629

Compare GSK to Peers and Sector

Metrics to compare
GSK
Peers
Sector
Relationship
P/E Ratio
23.9x18.1x−0.5x
PEG Ratio
0.000.030.00
Price/Book
4.5x2.1x2.6x
Price / LTM Sales
2.0x2.7x3.0x
Upside (Analyst Target)
0.0%20.3%56.3%
Fair Value Upside
Unlock29.3%10.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.632
Dividend Yield
2.62%
Annualised payout
0.6844
Paid unevenly
5-Years Growth
-9.41%
Growth Streak

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

1,657.00
BAES
+4.18%
75.72
BNPP
+2.95%
366.90
OREP
+3.40%
57.49
TTEF
+0.54%
530.2
NOVOb
+0.99%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.